135th Annual APHA Conference: Wednesday November 7, :30 am

Slides:



Advertisements
Similar presentations
STI Disclosure Self-Efficacy in Adolescent Females L. Lowery, B. Glass, P. Parham, & J. Ellen Johns Hopkins University School of Medicine Division of General.
Advertisements

The HPV Vaccine Our Best Shot to Prevent Cervical Cancer Harold C. Wiesenfeld, MD,CM Department of Obstetrics, Gynecology and Reproductive Sciences-University.
What is HPV? Estimated to be the most common sexually transmitted infection in the United States.
Human Papillomavirus and Cervical Cancer And ways to prevent it! Lindsey Saunders Auburn University NURS 7446 December 3, 2014.
Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.
By: Jennifer Cox.  HPV is the most common sexually transmitted disease affecting more than 20 million people in the U.S.  HPV is responsible for 70%
Patterns of Age Mixing and Sexually Transmitted Infections Julie Kraut-Becher University of Pennsylvania Sevgi O. Aral Division of STD Prevention, CDC.
1 Rachel Torres, MPH, CHES Department of Health & Behavior Studies Teachers College, Columbia University Relationships between Health Literacy, Self- efficacy.
Women’s First Health Center Drs. Sylvester, Youngren, Lo and Sansobrino What You Should Know About Cervical Cancer: Part one in a series of four updates.
HPV Related Disease Ginny Ryan. What Is HPV? The human papillomavirus is the most common sexually transmitted infection in the U.S. – 79 million Americans.
Facts and Prevention Presented By: Ashley Austin-Yearwood, John Cyril Quarshie, Lauren Decker, Jamison Halliwell.
1 Ch. 21. Health and Medicine Medical Sociology. Two states comparison 2.
USING TECHNOLOGY TO REACH DIVERSE POPULATIONS Versie Johnson-Mallard, PhD, MSc, MSN, WHNP-BC Assistant Professor, University of South Florida College of.
The Relationship Between Knowledge and Beliefs About Human Papillomavirus, Acceptance of the Human Papillomavirus Vaccine, and Intentions to Practice Safer.
Mass Media’s Portrayal of HPV Vaccination among Adolescent Males in Online News Content: A Framing Analysis Gabrielle Darville, MPH 1, Whitney D. Smith.
Barren River District Health Department Human Papillomavirus (HPV)
Factors Predicting Stage of Adoption for Fecal Occult Blood Testing and Colonoscopy among Non-Adherent African Americans Hsiao-Lan Wang, PhD, RN, CMSRN,
1 No glove, no love: Why California’s ethnic youth report using contraception Shelly Koenemann, MPH Marlena Kuruvilla, MPH/MSW Michelle Barenbaum, MPH.
Source: projectaccept.org. Did you know… HPV is the most common sexually transmitted infection in the U.S. Nearly all sexually active people will get.
1 Machismo as a determinant for HIV/STD risk behavior among Latino MSM Jacqueline L. Sears, MPH.
HPV-related anogenital cancers
1 Human Papillomavirus (HPV) Isaiah Aviles & Ashley Bermudez Senior Health 12 Block 2B March 2016.
Dacy Gaston NSG  According to the CDC (2014)  “Human papillomavirus (pap-ah-LO-mah-VYE-rus) (HPV) is the most common sexually transmitted virus.
Patterns of HPV vaccination among Latinos: Key factors for consideration Rachel A. Reimer, PhD Chair Department of Public Health Director MPH program Associate.
Chapter 29 Human Papilloma Virus Infection and Immunity.
Associations Between Recent Gender- Based Violence and Pregnancy, Sexually Transmitted Infections, Condom Use Practices, and Negotiation of Sexual Practices.
The HPV Vaccine Post- Licensure: Have Online News Stories Changed Over Time? A Follow-up Study. March 30, 2009 Presented by: Jillian R. Doss, MPH, Public.
Correlates of Never Using Condoms for Oral Sex Sara K. Head, MPH 1 Richard A. Crosby, PhD 1 Gregory Moore, MD 1 Adewale Troutman, MD 2 1 University of.
Sexual Health Update Produced by: Mike Huckabee, PhD, PA-C DIRECTOR: UNMC Physician Assistant Program Lincoln Pediatric Group.
Trends in HIV-Related Risk Behaviors Among U.S. Adolescents: 15 Years of Progress Laura Kann, Ph.D. Richard Lowry, M.D. Nancy Brener, Ph.D. Danice Eaton,
Cervical Cancer Awareness: HPV 101
Seeking HIV-testing Only: Missed Opportunity for HIV Prevention?
An Examination of HPV Vaccine Administration in Georgia
Sexually Transmitted Infections
Claudia L. Moreno, Ph.D., MSW
What is HPV? The Human papillomavirus, or HPV, is the most common sexually transmitted infection in the world today. Nearly all sexually active people.
Demographics of Parents
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
1University of Kentucky, Lexington, Kentucky
Disparities in Infectious Diseases Among Youth
Prevalence of Sexually Transmitted Infections and Bacterial Vaginosis among Female Adolescents in the United States: Data from the National Health and.
Psychosocial and behavioral predictors of partner notification for STD and HIV exposure among MSM Matthew J. Mimiaga, ScD, MPH, Sari L. Reisner, MA,
Diabetes and Hypertension Health Screening in the Fresno Sikh Population: A Cross Sectional Approach Baljit Singh Dhesi 1,2 1University of California,
HIV and STD Knowledge of a Sexually Diverse Group of Hispanic Male College Students Sandra “Sande” Gracia Jones, PhD, ARNP, ACRN, ACNS-BC, FAAN1; Eric.
HUMAN PAPILLOMAVIRUS VACCINE SERIES COMPLETION RATES AMONG PEDIATRIC, FAMILY MEDICINE, AND GYNECOLOGY CLINICS IN WEST TEXAS Joanne Thambuswamy, MD1, Fatma.
Designing and evaluating a health belief model (HBM) based intervention to increase intent of human papilloma virus (HPV) vaccination among male youth.
Lung Cancer Screening: Do Individual Health Beliefs Matter?
HPV VACCINES Dr. Kirtan Krishna.
Ch. 21. Health and Medicine Medical Sociology.
A study of high risk African American women, 15 to 21 years of age
Maya B. Mathur Castilleja School, Palo Alto, CA
Public Health Implications
Mandatory immunizations For children and adolescents (HPV)
Secondhand smoke exposure and cervical cancer:
10 Things You Should Know About HPV
Nasreen Abdullah, MD, MPH
Sexual Health Joy Schaubhut, MPH Public Health Educator
Dorcas Obori-Yeboah and team
STDs among Sexually Active Female College Students: Does Sexual Orientation or Gender of Sex Partner(s) Make a Difference? Lisa L. Lindley, DrPH, MPH,
Barriers to Cervical Cancer Screening Among Hispanic Women
10 Things You Should Know About HPV
Adolescents in Love: Mutuality of commitment in adolescent couples
The Relationship between Recent Alcohol Use and Sexual Behaviors/STDs: Gender Differences among STD Clinic Patients Heidi E. Hutton PhD, Mary E. McCaul.
Reproductive Systems Mini REVIEW
M Javanbakht, S Guerry, LV Smith, P Kerndt
Serik Tursunaliev, Veronica Ross
Isabel C. Scarinci, PhD, MPH James Kendrick, MD Edward Partridge, MD
African American and Hispanic Females and the Need for Early Detection
Megan Masters, MSN Candidate DePaul University School of Nursing
SEXUALLY TRANSMITTED INFECTIONS (STIs) PREVENTION & CARE
Presentation transcript:

135th Annual APHA Conference: Wednesday November 7, 2007 8:30 am Cognitive and emotional differences among HPV+ and HPV- men: Results of a pilot study of HPV in men in a natural history study 135th Annual APHA Conference: Wednesday November 7, 2007 8:30 am Daley E., PhD, Giuliano, A., PhD, Baldwin, J., PhD, Buhi, E.R., PhD, Lee, J.H., PhD, Vadaparampil, S., PhD, Abrahamsen, M., MPH, Vamos, C., MPH, Kolar, S., MSPHS1, Chandler, R., MS, Anstey, E., MS. Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, FL

Background: HPV HPV is the most common STI in the world Over 100 strains of HPV 30-40 strains are sexually transmitted Low-risk (non-oncogenic, genital warts) vs. High-risk HPV strains (oncogenic) Centers for Disease Control and Prevention. Genital HPV infection: CDC fact sheet. 2004. Available at: http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed September 24, 2007.

Background: HPV U.S. incidence ~ 6.2 million/year U.S. prevalence ~20 million >50% of sexually active US adults will be infected with HPV at some point >80% of sexually active women will have been infected by the virus by age 50 Centers for Disease Control and Prevention. Genital HPV infection: CDC fact sheet. 2004. Available at: http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed September 24, 2007.

HPV-Related Cancers in Men and Women Cervical Vaginal Vulvar Penile Anal Oropharyngeal % Assoc. with HPV >99% 50% >50% >70% 20% Gonazalez Intxaurraga MA, Stankovic R, Sorli R, Trevisan G. Acta Dermatovenerol.2002; 1:1-8.

Background: Cervical Cancer Worldwide: 2nd leading cause of female cancer mortality HPV prevalence ~ 440 million Cervical cancer deaths ~ 250,000 per/yr U.S. Estimates for 2006: 9,710 new cervical cancer cases 3,700 cervical cancer deaths World Health Organization. Human Papillomavirus. Available at: http://www.who.int/vaccine_research/diseases/viral_cancers/en/index3.html. Accessed October 15, 2007 American Cancer Society. Cancer Facts & Figures 2006. Available at: http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf. Accessed October 15, 2007

Current HPV Research CDC Study of HPV in Women – 5 main themes (stigma, anger, fear, self-blame, powerlessness) Psychosocial reactions in males  the male role in prevention of cervical cancer CER Study - Cognitive and Emotional Responses in Men To further our understanding of the cognitive and emotional responses to an HPV test result in men and how this influences their behavior Information is necessary for the development of HPV educational messages as well as HPV vaccine dissemination strategies targeting both genders

Purpose CER Study: To examine differences among HPV+ and HPV- men enrolled in a pilot study examining Cognitive and Emotional Responses to an HPV Diagnosis in Men (The CER Study -- 1R01 CA123346-01) Pilot Study: To identify the development of a cognitive and emotional survey instrument for this unique population

Methodology Prospective CER study is part of a large natural history study of HPV in men. This study will involve administering four quantitative surveys to a total of 500 men every six months over a two year follow-up period Validation sample N=30 (15 HPV+ men 15 HPV- men) Recruitment and enrollment of this population Time 1 (males tested for HPV); Time 2 (tested again); Time 3 (receive test results and are recruited for this behavioral study) Pilot Study: Paper-and-Pencil CER Study: Computer-Assisted Survey Instrument (CASI)

Methodology Instrument developed based on theoretical models Parallel Processing Model (Leventhal) Common Sense Model (revised by Leventhal) Extended Parallel Processing Model (Witte) Constructs highlighted in this presentation: Knowledge, Perceived threat, Response efficacy Demographic variables

CER Study - Model

CER Study - Measures Cognitive Responses Emotional Responses factors that help an individual understand what the illness or disease represents to them Emotional Responses fear, threat to the individual, severity Behavioral Intentions & Behavioral Change disclosure of test results to sexual partner(s), recommendations to sexual partner(s) to get screening Pap smears, intentions for HPV vaccinations

Results - Demographics Age Education Level N High School Diploma or GED 1 Some college credit, no college degree 19 College undergraduate degree (i.e. BA, BS) 9 College Masters or Doctoral Degree (i.e. MSW, PhD, MD)

Results - Demographics 3 out of the 30 men reported themselves as Hispanic or Latino

Results – HPV Dx Lab Test Results Self-Reported Results 3 out of 15 men reporting HPV+ were incorrect. 3 out of 14 men reporting HPV- were incorrect. 1 man reporting “unsure” was incorrect.

“You can have HPV without knowing it.” “Antibiotics can cure HPV.” Results - Knowledge Knowledge Score (0 – 100) Higher score = Greater knowledge 20 items (True, False, Not Sure) Mean = 73.85 (SD 3.45) Range = 15-95 No significant difference between HPV+ and HPV- men “HPV causes herpes.” “You can have HPV without knowing it.” “Antibiotics can cure HPV.”

Results – Perceived Threat Perceived Threat Score (0-40) Higher score = Greater perceived threat 8 items (Strongly Agree to Strongly Disagree) Mean = 17.13 (SD 5.52) Range = 7-29 No significant difference between HPV+ and HPV- men “In the time since I received my most recent HPV test result, I have been concerned about getting another STI.” “Having an abnormal Pap test is a serious threat to my partner’s health.” “I am concerned that I will get genital warts.”

Results – Response Efficacy Response Efficacy Score (0-25) Higher Score = Greater Response Efficacy 5 items (Strongly Agree to Strongly Disagree) Mean = 21.50 (SD 3.78) Range = 11-25 HPV- men reported greater response efficacy (23.7) than HPV+ men (19.9) (p=.02) “Suggestions that my partner have a Pap test helps prevent her form getting cervical cancer.” “By getting vaccinated against HPV when it becomes available for men I could reduce the risk of my sexual partner getting HPV.” “By using condoms I could reduce the risk of spreading/getting HPV.”

Discussion Only the construct response efficacy demonstrated significant differences between HPV+ and HPV- men High level of knowledge among these men We anticipate results will change over time Current study status: Approx. 80 men have completed Survey #1 - Results being presented at IPV (Beijing) Administering 2nd survey

Future Implications Men’s cognitive/emotional responses may be moderated by their ability to accurately report their own HPV status.  Future research should address this issue. Importance of clear and consistent educational messages to alleviate confusion and adverse psychosocial responses Further clinical trials on HPV vaccines (including male samples) and associated educational messages HPV’s role in other cancers (i.e. oral cancer)

Conclusion Male partners can play a critical role in cervical cancer prevention efforts Understanding men’s knowledge and appraisal processes concerning an HPV diagnosis can assist in prevention efforts to decrease HPV infections and cervical cancer rates Disclosure, decreasing risky sexual behaviors (number of partners, condom use, etc.), suggesting cervical cancer screening and HPV vaccine with partners

Principal Investigator Questions? This study is funded by the National Institutes of Health, National Cancer Institute (Grant# 1R01 CA123346-01). Ellen M. Daley, PhD, MPH Principal Investigator edaley@health.usf.edu